Raymond C Harris Selected Research

C.I. direct red 80

10/2022	Multiparametric magnetic resonance imaging in diagnosis of long-term renal atrophy and fibrosis after ischemia reperfusion induced acute kidney injury in mice.
11/2019	Noninvasive quantitative magnetization transfer MRI reveals tubulointerstitial fibrosis in murine kidney.
12/2018	Assessment of renal fibrosis in murine diabetic nephropathy using quantitative magnetization transfer MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond C Harris Research Topics

Disease

35	Fibrosis (Cirrhosis) 10/2022 - 04/2003
35	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 10/2006
22	Albuminuria 01/2021 - 01/2005
20	Hypertension (High Blood Pressure) 11/2018 - 03/2002
16	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 02/2000
9	Chronic Renal Insufficiency 01/2021 - 03/2015
9	Hyperglycemia 01/2020 - 12/2006
8	Inflammation (Inflammations) 01/2022 - 04/2002
7	Ischemia 10/2021 - 02/2000
7	Kidney Diseases (Kidney Disease) 10/2021 - 03/2014
6	Neoplasms (Cancer) 02/2021 - 01/2004
5	Insulin Resistance 01/2022 - 10/2017
5	Ureteral Obstruction 01/2018 - 04/2010
5	Reperfusion Injury 01/2018 - 07/2012
4	Renal Insufficiency (Renal Failure) 01/2022 - 10/2008
4	Diabetes Mellitus 01/2021 - 03/2004
4	Carcinogenesis 01/2016 - 04/2009
4	Hypertrophy 06/2015 - 05/2005
3	Hypoxia (Hypoxemia) 10/2021 - 06/2014
3	Type 2 Diabetes Mellitus (MODY) 10/2021 - 01/2018
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 06/2014
3	Adenoma (Adenomas) 10/2015 - 04/2009
3	Essential Hypertension 04/2012 - 11/2009
3	Proteinuria 07/2011 - 09/2002
2	Body Weight (Weight, Body) 01/2022 - 01/2021
2	Weight Gain 01/2022 - 03/2002
2	Obesity 01/2022 - 12/2018
2	Diabetes Complications 05/2015 - 01/2013
2	Polyuria 05/2015 - 04/2005
2	Wounds and Injuries (Trauma) 01/2013 - 10/2011

Drug/Important Bio-Agent (IBA)

17	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2004
12	SaltsIBA 11/2018 - 09/2002
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
10	CollagenIBA 01/2021 - 08/2004
9	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 01/2007
8	Dinoprostone (PGE2)FDA Link 01/2022 - 04/2009
8	Dopamine (Intropin)FDA LinkGeneric 03/2015 - 11/2009
7	Angiotensin IIIBA 10/2021 - 06/2006
6	ProstaglandinsIBA 01/2022 - 04/2005
6	CytokinesIBA 01/2022 - 12/2012
6	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2017 - 04/2003
6	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2011 - 09/2002
5	Messenger RNA (mRNA)IBA 10/2021 - 09/2002
5	SodiumIBA 11/2018 - 03/2002
5	Sirolimus (Rapamycin)FDA Link 07/2015 - 05/2005
5	Streptozocin (Streptozotocin)FDA Link 05/2015 - 09/2002
5	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2014 - 10/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2014
4	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 03/2015
4	RNA (Ribonucleic Acid)IBA 10/2021 - 05/2005
4	CreatinineIBA 12/2018 - 01/2007
4	Epidermal Growth Factor (EGF)IBA 01/2018 - 04/2003
4	Diphtheria ToxinIBA 12/2017 - 12/2012
4	TOR Serine-Threonine KinasesIBA 06/2014 - 05/2005
4	4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA 02/2007 - 09/2002
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2005 - 04/2002
3	C.I. direct red 80IBA 10/2022 - 12/2018
3	Losartan (Cozaar)FDA LinkGeneric 10/2021 - 11/2012
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2019
3	IntegrinsIBA 01/2020 - 05/2007
3	Phosphotransferases (Kinase)IBA 01/2019 - 01/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 07/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 05/2007
3	Tyrosine Kinase InhibitorsIBA 07/2016 - 06/2006
3	Superoxides (Superoxide)IBA 05/2015 - 06/2009
3	Dopamine Receptors (Dopamine Receptor)IBA 03/2015 - 01/2012
3	GlucocorticoidsIBA 09/2013 - 06/2005
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2009 - 03/2002
3	Indicators and Reagents (Reagents)IBA 01/2008 - 03/2007
2	Interferon Regulatory FactorsIBA 01/2022 - 01/2021
2	aristolochic acid I (aristolochic acid)IBA 01/2022 - 09/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2021 - 02/2012
2	Vasopressins (Vasopressin)IBA 01/2021 - 04/2005
2	AdiponectinIBA 01/2021 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 01/2018 - 10/2008
2	setogepramIBA 01/2018 - 01/2018
2	Insulin (Novolin)FDA Link 01/2018 - 12/2006
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 03/2014
2	AlbuminsIBA 01/2018 - 12/2006
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 09/2015
2	Caspase 3 (Caspase-3)IBA 10/2016 - 09/2014
2	Aquaporins (Water Channels)IBA 03/2016 - 10/2008
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2016 - 07/2015
2	Glycogen Synthase (Synthase I)IBA 08/2015 - 11/2012
2	Mechanistic Target of Rapamycin Complex 1IBA 07/2015 - 06/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013 - 11/2012
2	Superoxide DismutaseIBA 12/2012 - 06/2009
2	Captopril (Capoten)FDA LinkGeneric 11/2012 - 02/2012
2	Acetates (Acetic Acid Esters)FDA Link 11/2012 - 11/2009
2	Desoxycorticosterone (Deoxycorticosterone)IBA 11/2012 - 11/2009
2	GTP-Binding Proteins (G-Protein)IBA 04/2012 - 01/2012
2	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 08/2010 - 06/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2010 - 06/2006
2	Desoxycorticosterone Acetate (DOCA)FDA Link 11/2009 - 09/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2009 - 02/2007
2	Peptide Initiation Factors (Initiation Factor)IBA 09/2009 - 06/2006
2	Protein Isoforms (Isoforms)IBA 06/2009 - 04/2005

Therapy/Procedure

11	Therapeutics 01/2022 - 09/2004
6	Nephrectomy 10/2021 - 09/2002
3	Chemoprevention 10/2015 - 04/2009